• News
  • Sport
  • TV
  • Radio
  • Education
  • TV Licences
  • Contact Us
No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION
Home Sci-tech

PharmaMar shares soar after drug study suggests efficacy against Omicron

11 January 2022, 3:32 PM  |
Reuters Reuters |  @SABCNews
Workers walk outside the Spanish pharmaceutical company PharmaMar, amid the coronavirus disease (COVID-19) outbreak, in Colmenar Viejo, Spain January 26, 2021.

Workers walk outside the Spanish pharmaceutical company PharmaMar, amid the coronavirus disease (COVID-19) outbreak, in Colmenar Viejo, Spain January 26, 2021.

Image: Reuters

Workers walk outside the Spanish pharmaceutical company PharmaMar, amid the coronavirus disease (COVID-19) outbreak, in Colmenar Viejo, Spain January 26, 2021.

Shares in PharmaMar (PHMR.MC) jumped almost 20% on Tuesday after the Spanish drugmaker said lab trials suggested its Plitidepsin drug was effective against the main COVID-19 variants, including the highly contagious Omicron.

Results from in-vitro tests published in the Life Science Alliance journal showed that Plitidepsin, also known as Aplidin, had a potent antiviral effect in all variants and decreased the viral load detected in animal lung tissue by 99%, the company said.

The same paper also included previously published positive effects in Phase I and II clinical trials carried out on patients who were hospitalised with COVID-19.

The drug, originally developed as a cancer treatment, is now undergoing Phase III trials.

“All data we have seen so far with Plitidepsin corroborate our initial hypothesis about its antiviral activity,” PharmaMar Chairman Jose Maria Fernandez Sousa said in a statement.

Shares in the company rose 19% in early afternoon trade, on track for their best day in nearly a year. The shares had gained about 20% in January last year, also following encouraging news on Plitidepsin.

Alvaro Lenze, an analyst with Spanish brokerage Alantra, sounded a note of caution, however, saying it is too soon to draw definitive conclusions about the drug’s effectiveness against coronavirus variants.

“We also believe that PharmaMar’s opportunity in COVID is very limited, as its potential treatment would likely arrive too late,” he wrote in a note to clients.

Early data suggests that PharmaMar’s drug is less effective than rival treatments while its intravenous administration is less convenient than the pills produced by Pfizer (PFE.N) and Merck & Co. (MRK.N), Lenze added.

“We believe that the market reaction is disproportionate and see the rally as an opportunity to sell the stock.”

Share article
Tags: COVID-19Omicron variant
Previous Post

India’s COVID-19 vaccine maker seeks inroads into SA market

Next Post

Battle for ANC leadership heats up with just few months to elective conference in December

Related Posts

[File photo] Smoke and steam billows from Belchatow Power Station, Europe's largest coal-fired power plant operated by PGE Group, near Belchatow, Poland November 28, 2018.

Residents in Mpumalanga want municipalities to hold polluters accountable

6 February 2023, 12:48 PM
Medical staff wait to treat patients at a cholera centre.

Public urged to exercise personal hygiene following imported cholera cases 

6 February 2023, 12:01 PM
FILE PHOTO: Russian hacking underground newsletter is seen in this illustration taken, December 19, 2022 REUTERS/Dado Ruvic/Illustration/File Photo

Italy sounds alarm on large-scale computer hacking attack

5 February 2023, 8:39 PM
Tests for detection of Cholera

Minister Phaahla calls for vigilance as SA records two cholera cases

5 February 2023, 6:20 PM
A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services clinic in Seattle, Washington, U.S., March 20, 2019.

Cape Town on campaign to curb measles outbreak

5 February 2023, 1:19 PM
A green comet named Comet C/2022 E3 (ZTF), which last passed by our planet about 50,000 years ago and is expected to be most visible to stargazers this week, is seen journeying tens of millions of miles (km) away from Earth in this telescope image taken on January 21, 2023.

Green comet to be visible from SA next week

5 February 2023, 9:50 AM
Next Post
African National Congress (ANC) leadership in Polokwane.

Battle for ANC leadership heats up with just few months to elective conference in December

Most Viewed

  • 24hrs
  • Week
  • Month
  • Registration at Unisa closes on Friday, but management says no need to panic
  • Green comet to be visible from SA next week
  • VIDEO: Mabuza resigns as SA Deputy President
  • Budding Stellenbosch FC star reportedly stabbed to death
  • Shock over proposed SA sponsorship of Tottenham Hotspur
  • Parts of the Northern Cape to be exempted from rolling blackouts
  • Registration at Unisa closes on Friday, but management says no need to panic
  • VIDEO | St Benedict College’s Matric learner gets 11 distinctions
  • Limpopo matriculant from child-headed household attains diploma pass
  • Female circumcision practice thriving in Eastern Cape
  • Kellerman, Bantwini, Zikode win Grammy award
  • We are not moved by threats made by Malema: Mbalula
  • Former Orlando Pirates midfielder John Moeti passes away
  • EFF expresses concern over ‘secrecy’ around Mabuza’s resignation
  • ‘If you are lazy, stay home’, Mbalula advises ANC members

LATEST

Close to 1 800 people have been confirmed to have died in the quakes that have injured thousands of others in the two countries.
  • Politics

Malema offers condolences to Turkey and Syria following earthquakes


  • Uncategorized

SONA 2023


  • Business

Mining production hampered by intense rolling blackouts: Minerals Council


Adv Tembeka Ngcukaitobi SC, representing Competition Commission in this matter
  • Business

Sasol urges Nersa to set the price rather than Competition Tribunal


[File Photo] the National Assembly.
  • Politics

NFP and ANC file motions of no confidence against IFP office bearers in Nongoma


A Transnet locomotive seen on a track
  • Business

Transnet takes steps to mitigate and minimise rolling blackouts


Weather

  • About the SABC
  • Contact Us
  • Jobs
  • Advertise
  • Disclaimer
  • Site Map

SABC © 2023

No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION

© 2022

Previous India’s COVID-19 vaccine maker seeks inroads into SA market
Next Battle for ANC leadership heats up with just few months to elective conference in December